Plasmocure™

Mycoplasma Elimination Guaranteed !

In very rare cases, mycoplasmas resistant to Plasmocin™ have been reported. To eradicate these mycoplasmas, InvivoGen has developed a new antimycoplasma agent called Plasmocure™.
Plasmocure™ combines two antibiotics that act through different mechanisms of action than those in Plasmocin™.
A two week treatment with Plasmocure™ was found sufficient to completely eliminate mycoplasmas.
A moderate toxicity can be observed during the course of the treatment but full recovery of the cell line is expected once mycoplasmas are eliminated.

Plasmocure™ is a sterile ready-to-use solution. Simply add to mycoplasma contaminated cell cultures for 2 weeks at the recommended concentration of 50 μg/ml.

Content 

Plasmocure™ is provided as a colorless solution at a concentration of 100 mg/ml. One ml Plasmocure™ is enough to treat 2 L medium.
Plasmocure™ is shipped at room temperature. Store at -20°C.
Plasmocure™ is stable one year at 4°C or -20°C.


ProductTDS MSDSQtyCat.
Code
Price Order 
Plasmocure™PDFPDF100 mg ant-pccheck cart

Disclaimer: Our products are provided for research purpose only. Commercial applications may require licensing from third parties.
Note that the sequence of available ORFs provided by InvivoGen can differ from a given reference Genbank record due to genetic variations and/or alternative splicing. Customers should verify that the version of a gene sold by InvivoGen is suitable for the customer needs.

Copyrights © 2010 InvivoGen. All Rights Reserved. Reproduction of any materials from this site is strictly forbidden without permission for commercial use. Nonprofit use for non-commercial research and educational purposes is permitted, citation should include the URL "www.invivogen.com".